Primary age ‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis

EBV ‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis. AbstractEBV ‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis.

Source: Clinical Case Reports - April 5, 2021 Category: General Medicine Authors: Justin J. Kuhlman, Muhamad Alhaj Moustafa, Alexander J. Tun, David M. Menke, Han W. Tun, Liuyan Jiang Tags: CASE REPORT Source Type: research